Show simple item record

dc.contributor.advisorAsaduzzaman, Muhammad
dc.contributor.authorZangmo, Thinley
dc.date.accessioned2024-10-03T06:43:15Z
dc.date.available2024-10-03T06:43:15Z
dc.date.copyright©2024
dc.date.issued2024-07
dc.identifier.otherID 20346071
dc.identifier.urihttp://hdl.handle.net/10361/24297
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.en_US
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 34-39).
dc.description.abstractSmall cell lung cancer is the most aggressive form of cancer and its progression is very fast and quick. The NF-kB pathway and small cell lung cancer are connected to each other. Despite all the findings and the advanced technologies, due to its challenges associated with its aggressive progressions of small cell lung cancer, only few clinical trials are currently available for SCLC. It has limited treatment options and lacks the targetable biomarkers (Patel & Das, 2023). The NF-kB pathway extensively regulates the pathogenesis of SCLC by promoting tumor development and progression. Additionally, the irregular activation of NF-κB can lead inflammation, development of the autoimmune diseases and malignant disorders, namely atherosclerosis and malignant neoplasm (Park & Hong, 2016). Therefore, it's important to understand and to identify how NF-κB pathway influences the progression of the cancer in the SCLC through the application of the various bioinformatics tools. This study highlights how NF-κB pathway influences the progression of the cancer. The present study also helps in the identification of the key genes that are responsible for SCLC in the NF-κB pathway using the spearman’s correlation limit, finding the numbers of correlated genes and filtering the genes by using different bioinformatics techniques and approaches. NFKB2, ITGB2, PRKCD, RELB, BCL3, STAT6 and RIPK1 play critical role in the cellular growth and progression, cell survival, apoptosis, immune response and survival of the cancer patients. Finally, understanding the survival rate of the patient and pinpointing the critical pathways that can be targeted.en_US
dc.description.statementofresponsibilityThinley Zangmo
dc.format.extent51 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectLung canceren_US
dc.subjectNF-kB pathwayen_US
dc.subjectSNPen_US
dc.subjectCo-expressed genesen_US
dc.subjectDifferentially expressed genesen_US
dc.subject.lcshLungs--Cancer--Treatment.
dc.subject.lcshLungs--Cancer--Molecular aspects.
dc.subject.lcshBioinformatics.
dc.titleBioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinomaen_US
dc.typeThesisen_US
dc.contributor.departmentSchool of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record